Literature DB >> 8417174

Recommendations for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. U.S. Public Health Service Task Force on Antipneumocystis Prophylaxis in Patients with Human Immunodeficiency Virus Infection.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8417174

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN： 0894-9255


× No keyword cloud information.
  4 in total

1.  Frequency and determinants of use of antiretroviral and prophylactic therapies against Pneumocystis carinii Pneumonia (PCP) before AIDS diagnosis in Italy.

Authors:  P A Napoli; M Dorrucci; D Serraino; P Pezzotti; S Franceschi; S Vella; G Rezza
Journal:  Eur J Epidemiol       Date:  1998-01       Impact factor: 8.082

2.  Predicting cutaneous hypersensitivity reactions to cotrimoxazole in HIV-infected individuals receiving primary Pneumocystis carinii pneumonia prophylaxis.

Authors:  S Hennessy; B L Strom; J A Berlin; P J Brennan
Journal:  J Gen Intern Med       Date:  1995-07       Impact factor: 5.128

3.  Health insurance and utilization in Pneumocystis carinii pneumonia.

Authors:  S Loue; D J Slymen; H Morgenstern; C Whalen
Journal:  J Gen Intern Med       Date:  1995-08       Impact factor: 5.128

Review 4.  The effects of long term zidovudine therapy and Pneumocystis carinii prophylaxis on HIV disease. A review of the literature.

Authors:  D R Hoover
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.